PPARα activators may play role for the regression of ventricular hypertrophy in hypertensive and hyperlipidemic patients [9]

Simple item page
dc.contributor.authorErol A.
dc.date.accessioned2024-07-22T08:23:35Z
dc.date.available2024-07-22T08:23:35Z
dc.date.issued2006
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1016/j.mehy.2005.12.001
dc.identifier.issn03069877
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/19590
dc.language.isoEnglish
dc.subjectAntilipemic Agents
dc.subjectClinical Trials
dc.subjectEvidence-Based Medicine
dc.subjectHumans
dc.subjectHyperlipidemias
dc.subjectHypertension
dc.subjectHypertrophy, Left Ventricular
dc.subjectModels, Cardiovascular
dc.subjectPPAR alpha
dc.subjectProcetofen
dc.subjectTreatment Outcome
dc.subjectfenofibrate
dc.subjectperoxisome proliferator activated receptor alpha
dc.subjectantilipemic agent
dc.subjectfenofibrate
dc.subjectperoxisome proliferator activated receptor alpha
dc.subjectblood pressure regulation
dc.subjectheart muscle cell
dc.subjectheart ventricle hypertrophy
dc.subjecthuman
dc.subjecthyperlipidemia
dc.subjecthypertension
dc.subjectletter
dc.subjectlipid metabolism
dc.subjectlipoprotein metabolism
dc.subjectnonhuman
dc.subjectoxidative stress
dc.subjectpriority journal
dc.subjectremission
dc.subjectbiological model
dc.subjectclinical trial
dc.subjectdrug potentiation
dc.subjectevidence based medicine
dc.subjectheart left ventricle hypertrophy
dc.subjecthyperlipidemia
dc.subjecthypertension
dc.subjectmetabolism
dc.subjecttreatment outcome
dc.titlePPARα activators may play role for the regression of ventricular hypertrophy in hypertensive and hyperlipidemic patients [9]
dc.typeLetter

Files

Collections

Scopus Koleksiyonu